Clinical Trials Browser

Phase 2 × Bone Diseases, Metabolic × Zoledronic Acid × Clear all

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Phase 2 Completed

Bone Diseases, Metabolic, Prostatic Neoplasms